Steven Cohen Eledon Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $130,732 - $207,036	-53,360 Reduced 12.46%	375,000 $1.04 Million
Q2 2022 Aug 15, 2022	SELL	$2.34 - $3.96 $298,431 - $505,038	-127,535 Reduced 22.94%	428,360 $1.05 Million
Q1 2022 May 16, 2022	BUY	$3.06 - $4.89 $380,847 - $608,609	124,460 Added 28.85%	555,895 $2.19 Million
Q4 2021 Feb 14, 2022	BUY	$4.02 - $6.07 $892,218 - $1.35 Million	221,945 Added 105.95%	431,435 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.46 $123,552 - $175,968	20,800 Added 11.02%	209,490 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$7.62 - $11.75 $485,317 - $748,357	63,690 Added 50.95%	188,690 $1.49 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $19.22 $1.23 Million - $2.4 Million	125,000 New	125,000 $1.34 Million

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.